We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Paper-Based TB Test Could Increase Diagnoses Worldwide

By LabMedica International staff writers
Posted on 26 Sep 2017
In resource-limited areas, equipment requirements and long wait times for results are obstacles to early diagnosis and treatment of tuberculosis (TB). More...
To tackle this problem, scientists have developed a rapid colorimetric TB assay using gold nanoparticles on a paper-based device than enables results to be read with a smartphone.

Most of deaths from TB occur in low- and middle-income countries and remote areas. Conventional methods such as sputum smear microscopy, chest X-rays, and molecular-based tests require equipment, electricity, and specialized personnel. So lead researcher Chien-Fu Chen, professor at National Taiwan University (Taiwan), and colleagues from Chang Gung Memorial Hospital (Taiwan) and elsewhere in Taiwan, set out to come up with a more practical diagnostic test that can be read with a smartphone, a technology that is becoming increasingly available in emerging economies.

The researchers combined gold nanoparticles with single-stranded DNA (ssDNA) sequences that bind to the genetic material of Mycobacterium tuberculosis. These nanoparticles were then incorporated into a paper-based device. Adding even a minute amount of lab-derived, double-stranded DNA (dsDNS) from M. tuberculosis changed the color of the test spots within an hour. Furthermore, multiple tests could be performed simultaneously with a 60 min turnaround time.

A smartphone camera was used to analyze the color change to determine the bacterial concentration. The researchers also tested a tissue sample from an infected patient to further demonstrate that the device could be used in the field.

The study, by Tsai TT et al, was published September 13, 2017, in the journal ACS Sensors.

Related Links:
National Taiwan University
Chang Gung Memorial Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.